Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus
Add to Reading List
Open Document
File Size: 49,46 KB
Share Result on Facebook
Company
AMD /
ThromboGenics Inc. /
Genentech Inc. /
M.D. /
/
Event
FDA Phase /
/
Facility
Meeting FDA White Oak Campus /
White Oak Conference Center /
/
MedicalCondition
macular hole /
diabetic macular edema /
retinal vein occlusion /
macular degeneration /
Inc. Therapeutic Rationale Diabetic Macular Edema /
/
Organization
Dermatologic and Ophthalmic Drugs Advisory Committee /
Center for Drug Evaluation and Research /
office of New Drugs /
FOOD AND DRUG ADMINISTRATION /
office of Antimicrobial Products /
Ophthalmology Products /
Ophthalmic Drugs Advisory Committee /
/
Person
Hearing Rhea Lloyd /
Michael X. Repka /
Yvette Waples /
/
Position
Federal Officer /
Medical Officer /
Deputy Director /
Division of Transplant /
/
Product
Ranibizumab injection /
LUCENTIS /
/
SocialTag
Pharmacology
Dermatologic and Ophthalmic Drugs Advisory Committee
Center for Drug Evaluation and Research
Ranibizumab
Genentech
Macular degeneration
Macular edema
Intravitreal administration
Food and Drug Administration
Medicine